Clinical Trial Update: Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial assessing GSK's adjuvant combinations with the Hepatitis B vaccine antigen completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2013-01-25